Sheraton Hotel – Dammam Jan. 25-26 2019

13th  Middle East Best of San Antonio Breast Cancer Symposium

about-us

ABOUT THE EVENT

The 13th Middle East Best of SABCS allows professionals, who are unable to travel to San Antonio, the opportunity to experience and discuss the research and advances with colleagues and key opinion leaders.  Hence, the attendees to the 13th Middle East Best of SABCS program will receive the most current information on breast cancer research presented in the original format delivered at the meeting in San Antonio in December 2018. Moreover, you will learn of the current advances in breast cancer research that are changing clinical practice for the benefit of patients.
Principal subject areas of the 13th Middle East Best of SABCS program include:

  • Cancer Immunology 101.
  • Triple Negative Breast Cancer.
  • Breast Cancer Prevention: Consolidating Gains and Charting New Directions.
  • Follow-up Care and Lifestyle Recommendations to Improve Outcomes.
  • HER2+ Breast Cancer and,
  • Assessment and Treatment of Older Adults with Breast Cancer

Chairman Message

The Organizing Committee of the 13th Middle East Best of San Antonio Breast Cancer Symposium and the Saudi Cancer Foundation welcome you to 13th Middle East Best of SABCS™. SABCS™ is now in its 41 year, is the premier conference for basic, translational, and clinical cancer research professionals. It is well known for presenting the latest breast cancer data from all over the world. The Best of SABCS™ allows professionals, who are unable to travel to San Antonio, the opportunity to experience and discuss the research and advances with colleagues and key opinion leaders. Attendees to the Best of SABCS™ program will receive the most current information on breast cancer research presented in the original format delivered at the meeting in San Antonio in December 2018. You will learn of the current advances in breast cancer research that are changing clinical practice for the benefit of patients.

Sincerely,

Omalkhair Abulkhair, MD

Chairman of 13th Middle East Best of SABCS™ “

DOWNLOAD BROCHURE
Dr-Abu-El-Kheir-photo
committee-1000x1133

MESABCS 2019 COMMITTEES

MEET THE 2019 COMMITTEE
Chairman: Dr. Omalkhair Abulkhair
Co-Chairman: Dr. Ahmed Saadeddin
 
Members:
  • Dr. Abdulaziz Alsaif
  • Dr. Taher Altwaigri
  • Dr. Lobna Sedki
  • Dr. Hulayel Alharbi
  • Dr. Jamal Zekri
Chairman: Dr. Ahmed Saadedin
Co-Chairman: Dr. Omalkhair Abulkhair
 
Members:
  • Dr. Abdulaziz Alsaif
  • Dr. Eyad Alsaeed
  • Dr. Shahina Dawod
  • Dr. Metaeb Al Fohaidi
  • Dr. Jean Mark Nabholtz
  • Dr. Heba Zawary

Chairman: Dr. Adel Sayes

Co-Chairman: Dr. Omalkhair Abulkhair

Co-Chairman: Dr. Wael Melouk

 

Members:

  • Donabel Bigtas
  • Shehab Hashim

Participated Faculties

Faculties of 7 different countries under one roof

At the 13th Best of Middle East San Antonio Breast Cancer Symposium you will get the chance to network with professionals from 7 different countries. Check the list of faculties from the tabs below:

Dr. Hamdy Azim
Dr. Lobna Sedky
Dr. Alaa Kandil
Dr. Nasr Allahloubi
Dr. Maher Aidarous
Dr. Heba Zawary
Dr. Samir Shehata
Dr. Hassan Jaafar
Dr. Falah Al Khatib
Dr. Sami Al Khatib
Dr. Belal El Hawwari
Dr. Hikmat Abdelrazek
Dr. Sana Al Sukhun
Dr. Mahmoud Al Masri
Dr. Salah Fayaz
(Riyadh – KFSHRC)
Dr. Taher Tweigeri
Dr. Adhar Al Sayed
Dr. Dahish Ajarim
Dr. Essam Murshid
Dr. Osama Al Malik
Dr. Kawthar Soliman
(Riyadh – King Khaled Hospital)
Prof. Jean Marc Nabholtz
Dr. Khaled Saleh
Dr. Abdulaziz Al Saif
(Riyadh – NGHA Jeddah)
Dr. Meteb Foheidi
Dr. Ahmed Al Shehri
Dr. Yasir Bahadur
Dr. Jamal Zekri 
Participated-Faculties

HURRY UP! ABSTRACT SUBMISSION IS NOW OPEN…

Deadline of Abstract Submission is 1st January 2019

Who-should-attend

WHO SHOULD ATTEND

Shall I attend?!!

Wonder if this event suites you or not? Here’s a list of those professions that this event was made for. If you are one of them, you will probably make a good use of attending the event.

  • Medical Oncologists
  • Surgeons
  • Radiation Oncologists/ Radiologists
  • Pathologists
  • Oncology Nurses
  • Oncology-Genetics
  • Scientists
  • Medical Education & Social Workers
  • Patient Advocates

CONFERENCE AGENDA

Day 1 Agenda

Friday, 25 January 2019

9:00AM

Welcome and Opening Remarks

9:00AM - 9:10AM

9:10AM

EARLY BREAST CANCER

9:10AM - 12:05pM

Chairpersons: Dr. Dahish Ajarim, Dr. Lobna Sedky, Dr. Abdullah Al Twairgi & Dr. Sami Khatib

09:10am – 09:25am GS1-10. Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: primary results from KATHERINE

Speaker: Dr. Hulayel Alharbi

09:25am – 09:40am GS2-07. PHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer

Speaker: Dr. Khaled Al Saleh

09:40am – 09:55am GS2-03. Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and mortality, stratified by breast cancer subtypes and adjuvant chemotherapy usage: Individual patient-level meta-analyses of over 27,000 patients

Speaker: Dr. Ahmed Alwabari

09:55 am – 10:55 am SATELLITE SYMPOSIUM BY ROCHE (live webcast)

Speaker: Dr. Martine Piccart

10:55am – 11:10am Discussion

Speaker: Dr. Hamdy Azim

11:10am – 11:20am   Break

11:20am – 11:35am GS2-04. Efficacy results from CIBOMA/2004- 01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

Speaker: Dr. Hesham El Ghazaly

11:35am – 11:50am GS2-02. Efficacy and utilization trends of adjuvant chemotherapy for stage I, II, and III breast cancer in the elderly population: A National Cancer Database (NCDB) analysis

Speaker: Dr. Mohammed Rahal

11:50am – 12:05pm Discussion

Speaker: Dr. Ahmed Alfaraj 

12:05PM

PRAYER AND LUNCH BREAK

12:05PM - 1:00PM

1:00PM

1:00PM - 2:15PM

Chairpersons: Dr. Heba Zawary, Dr. Ahmed Al Shehri & Dr. Adda Bounedjar

1:00am – 1:15am GS3-01. A randomized placebo controlled phase III trial of low dose tamoxifen for the prevention of recurrence in women with operated hormone sensitive breast ductal or lobular carcinoma in situ

Speaker: Dr. Bassim Bahrani

1;15pm – 1:30pm GS3-02. PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib

Speaker: Dr. Emad Hamada

1:30pm – 1:45pm GS3-03. Effects of prolonging adjuvant aromatase inhibitor therapy beyond five years on recurrence and cause-specific mortality: an EBCTCG meta-analysis of individual patient data from 12 randomised trials including 24,912 women

Speaker: Dr. Sana Sukhun

1:45pm – 2:00pm GS3-04. A prospective randomized multi-center open-label phase III trial of extending aromatase- inhibitor adjuvant therapy to 10 years – Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS)

Speaker: Dr. Hikmat Abdelrazeq

2:00pm – 2:15pm Discussion

Speaker: Dr. Ezzeldin Ibrahim

 

2:15PM

SATELLITE SYMPOSIUM BY LILLY

2:15PM - 2:45PM

Abemaciclib and the MONARCH study program

Speaker: Dr. Akif Izhar

2:45PM

PRAYER AND BREAK

2:45PM - 3:15PM

3:15PM

METASTATIC BREAST CANCER

3:15PM - 4:30PM

Chairpersons: Dr. Fahad Bin Shamsa, Dr. Falah Al Khatib, Dr. Nasr Allahloubi & Dr. Sharif Kullab

3:15pm – 3:30pm  GS1-08. Genomic characterisation of metastatic breast cancer

Speaker: Dr. Taher Tweigeri

3:30pm – 3:45pm GS1-04. IMpassion130: Efficacy in immune biomarker subgroups from the global, randomized, double-blind, placebo-controlled, phase III study of atezolizumab + nab-paclitaxel in patients with treatment-naïve, locally advanced or metastatic triple-negative breast cancer

Speaker: Dr. Alaa Kandil

3:45pm – 4:00pm GS3-07. Clinical utility of circulating tumor cell count as a tool to choose between first line hormone therapy and chemotherapy for ER+HER2- metastatic breast cancer: Results of the phase III STIC CTC trial

Speaker: Dr. Jamal Zekri

4:00pm – 4:15pm GS3-08. Alpelisib + fulvestrant for advanced breast cancer: Subgroup analyses from the Phase III SOLAR-1 trial

Speaker: Dr. Meteb Foheidi

4:15pm – 4:30pm Discussion

Speaker: Prof. Jean Marc Nabholtz

04:30pm

END OF DAY 1

04:30pm -

8:00PM

OPENING CEREMONY, GALA DINNER & ABSTRACT AWARDING

8:00PM - 10:00PM

Day 2 Agenda

Saturday, 26 January 2019

8:30AM

LOCO-REGIONAL (SURGERY)

8:30AM - 9:30PM

Chairpersons: Dr. Abdulaziz Al Saif & Dr. Mahmoud Al Masri

8:30am – 8:45am Plenary session:

Hold that scalpel! – Using the tumor to determine the treatment

Speaker:  Dr. Ahmed Saadeddin

8:45am – 09:00am GS4-01.Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981/22023)

Speaker: Dr. Khalid Hajri

9:00am – 9:15am GS6-01. Surgical treatment after neoadjuvant systemic therapy in young women with breast cancer: Results from a prospective cohort study

Speaker: Dr. Jamila Al Azhri

9:15am – 09:30am Discussion

Speaker: Dr. Osama Almalik

9:30AM

BREAK

9:30AM - 9:45AM

9:45AM

RADIATION

9:45AM - 10:45AM

Chairpersons: Dr. Adnan Hebshi,  Dr. Eyad Alsaeed & Dr. Ahlam Dohal

9:45am – 10:00am GS4-03. RAPID: A randomized trial of accelerated partial breast irradiation using 3- dimensional conformal radiotherapy (3D-CRT)

Speaker: Dr. Essam Murshid

10:00am – 10:15am GS4-04. Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer

Speaker: Dr. Belal El Hawwari

10:15am – 10:30am GS4-02. Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials

Speaker: Dr. Majid Al Othman

10:30am – 10:45am Discussion

Speaker: Dr. Yassir Bahadur

10:45AM

SATELLITE SYMPOSIUM BY NOVARTIS

10:45AM - 11:15AM

CDK4 Inhibitors Update

Chairpersons: Dr. Omalkhair Abulkhair & Dr. Fahad Bin Shamsa

Speaker: Dr. Ahmed Saadeddin

 

11:15AM

SATELLITE SYMPOSIUM BY PFIZER

11:15AM - 11:45AM

CDK4 Inhibitors Update

Chairpersons: Dr. Omalkhair Abulkhair Dr. Meteb Foheidi

Speaker: Dr. Shadi Khayyat

 

11:45AM

11:45AM - 12:15PM

WHY UPFRONT USE OF CDK INHIBITORS FOR THE TREATMENT OF ADVANCE BREAST CANCER MAY BE WASTEFUL:
I WILL DO: YES IT IS WASTEFUL
Dr. Taher Tweigeri

SOMEBODY WILL DO: NO IT IS NOT WASTEFUL Prof. Jean Marc Nabholtz

12:15PM

PRAYER AND LUNCH BREAK

12:15PM - 1:15PM

1:15PM

SUPPORTIVE SPECIAL ISSUE – CARDIAC PREVENTION

1:15PM - 2:15PM

Chairpersons: Dr. Hafez Ghanem, Dr. Abdulrahman Elkinge & Dr. Samir Shehata

1:15pm – 1:30pm GS5-01. A randomized community-based trial of an angiotensin converting enzyme inhibitor, lisinopril or a beta blocker, carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving adjuvant trastuzumab

Speaker: Dr. Omar Shebl Zahra

1:30pm – 1:45pm  GS5-03. Lifestyle intervention and effect on disease-free survival in early breast cancer pts: Interim Analysis from the randomized SUCCESS C study

Speaker: Dr. Abdulnaser Nourallah

1:45pm – 2:00pm

GS6-06. Local therapy and quality of life outcomes in young women with breast cancer

Speaker: Dr. Huda Abdulkareem

2:00pm – 2:15pm Discussion

Speaker: Dr. Majid Aljahel

2:15PM

ABSTRACT PRESENTATIONS

2:15PM - 3:00PM

Abstract Scientific Committee Members Dr. Ahmed Saadeddin Dr. Omalkhair Abulkhair Dr. Meteb Foheidi

Dr. Sami Khatib
Dr. Abdulaziz Al Saif
Dr. Abdulmohsen Kushi Dr. Lobna Sedky
Dr. Maher Aidarous
Dr. Kamal Hamed

3:00PM

CLOSING REMARKS

3:00PM -

Dr. Omalkhair Abulkhair

Register Now

Free Registration is now available!! If you are one of the following, you are more than welcomed to register your attendance completely free:

  • Consultants, Radiologists & Surgeons
  • Non-consultants & Nurses
  • Fellows, Medical Education & Patient Advocates
  • 13th Middle East Best of San Antonio Breast Cancer Symposium
    25 - 26 January 2019
  • Conference Place Address

    Sheraton Dammam Hotel & Convention Centre
    Prince Mohammed Bin Fahd Road, Al Mazruiyah, Dammam 32414, Saudi Arabia

  • Send an Email

    donabelbigtas@dal-mark.com

  • Conference Coordinator

    Ms. Donabel V.Bigtas

  • Take a Look in Our Website

    www.mesabcs.com

  • +966 50 017 4313

This event brought to you by